Tel.:
+34 91 736 2385
LOCAL TIME
Contact:
Katarina Gluic
Hours:
Mon-Thu 8:30-17:00 Fri 8:30-15:00
15:19
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments
WFH 2016 World Congress
24-28 July 2016 Orlando
About us
FAQs
Help Line
Personal Area
Homepage
Discussion forum -
WFH 2016 World Congress
Topic -
Pharmacokinetics
If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER
Thread / Poster
Author
Replies
Last reply
Pharmacokinetics of a novel extended half-life glycoPEGylated factor IX, nonacog beta pegol (N9-GP) in previously treated adult, adolescent, and paediatric patients with haemophilia B results from two phase 3 trials
Jasper Jacobsen
1
7/21/2016 12:41:00 PM
Pharmacokinetic (PK) profiles in boys with hemophilia A assessed using a population PK Program (myPKFiT) and WinNonlin
Koyo Usuba
1
7/18/2016 2:41:00 PM
The pharmacokinetics characteristics of plasma-derived and recombinant FVIII products in Chinese children with severe hemophilia A.
Zhenping Chen
1
7/7/2016 8:11:00 PM
In silico evaluation of limited blood sampling strategies for individualized recombinant factor IX prophylaxis in hemophilia B patients
Tim Preijers
1
7/7/2016 2:16:00 PM
Comparison of pharmacokinetic (PK)-guided prophylactic dosing tools in hemophilia A - a pilot study
Tim Preijers
1
7/7/2016 2:05:00 PM
Is weight-based adjustment of factor VIII dosage required for underweight or overweight Japanese patients with hemophilia A?
Megumi Noguchi
1
7/7/2016 1:22:00 PM
Pharmacokinetic (PK)-guided daily dosing: a significant reduction in weekly clotting factor VIII consumption
Iris van
1
7/7/2016 10:05:00 AM
Population pharmacokinetic model of recombinant single-chain factor VIII (rVIII SingleChain) in patients with hemophilia A
Ying Zhang
1
7/5/2016 4:24:00 PM
Pharmacokinetics of a plasma-derived von VWF/FVIII concentrate (Voncento) in adult/adolescent and pediatric subjects with severe hemophilia A (SWIFT-HA and SWIFTLY-HA studies)
Wilfried Seifert
1
7/4/2016 4:25:00 PM
Population pharmacokinetic modeling of factor IX activity after administration of nonacog alfa in patients with hemophilia B
Joan Korth-Bradley
1
6/28/2016 3:27:00 PM
Single center clinical and pharmacokinetic experience with long-acting recombinant factor VIII (rFVIIIFx) and IX (rFIXFc)
Devin Malik
1
6/26/2016 12:53:00 AM
Most viewed poster for this congress
Poster:
13
Visits:
590
Title:
Algorithmic evidence-based phenotype screening and collaborative approach to attacking symptoms of nonadherence in patients with bleeding disorders
Authors:
Jay Bryant-Wimp , Jay Bryant-Wimp, RPh
Centre:
Integrite Solutions
Poster most viewed in this topic
Poster:
142
Visits:
21
Title:
Population pharmacokinetic model of recombinant single-chain factor VIII (rVIII SingleChain) in patients with hemophilia A
Authors:
YING ZHANG , J Roberts, D Bensen-Kennedy, A Veldman, K St Ledger, J Sidhu
Centre:
CSL Behring
About us
Terms and Conditions
Special Access
Commercial Web Access
Follow us on:
